Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts.
CONCLUSIONS: There is a wide heterogeneity of anti-NT5C1A antibody immunoreactivity. Some populations of SARDs are positive for anti-NT5C1A are also positive for anti-NT5C1A. However, the anti-NT5C1A frequencies in the patients with SARDs are low also in Japanese.
PMID: 28687351 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Chemistry - Category: Chemistry Authors: Muro Y, Nakanishi H, Katsuno M, Kono M, Akiyama M Tags: Clin Chim Acta Source Type: research
More News: Autoimmune Disease | Chemistry | Dermatology | Dermatomyositis | Inclusion-Body Myositis | Japan Health | Lupus | Polymyositis | Rheumatology | Scleroderma | Study